drugset / Trial / NCT00355251
Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption
Phase 4
Terminated
5 enrolled
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine the influence of atorvastatin on plasma viral replication when the latter is given before and during highly active anti-retroviral therapy (HAART) in patients with HIV infection and viral suppression.
Timeline
- Start
- 2006-07
- Primary completion
- 2006-12
- Completion
- 2007-02
Outcome
Outcome not reported
Stopped: “On the basis of published results of SMART study, it has been observed that the results are worse in patients who have interrupted their treatments.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 80 mg | — |